Work

Figure S3 from HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer

Year: 2023

Type: other

Abstract: Figure S3 shows that the effects of HDAC6 inhibitor ACY1215 alone or in combination with anti-PD-L1 on tumor immune microenvironment and that the combination of HDAC6 inhibitor ACY1215 and anti-PD-L1 does not affect the body weight of the treated mice.

DOI: 10.1158/0008-5472.22426249.v1

Authors: Takeshi Fukumoto, Nail Fatkhutdinov, Joseph A. Zundell, Evgenii N. Tcyganov, Timothy Nacarelli, Sergey Karakashev, Shuai Wu, Qin Liu, Dmitry I. Gabrilovich, Rugang Zhang

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361821588

Cites:

Cited by:

Related to: 10